International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-12
PHARMACOGENOMICS AND ITS ROLE IN PERSONALIZED MEDICINE DEVELOPMENT
Abstract
Pharmacogenomics has become an important field of modern clinical pharmacology because it examines how
genetic variations influence individual responses to pharmaceutical treatments. It provides a scientific foundation
for personalized medicine by helping healthcare professionals understand why patients may respond differently to
the same medication. Traditional treatment approaches generally depend on standardized prescribing practices,
which may not always produce equally effective results because individuals possess different genetic characteristics,
metabolic activities, and biological responses. Pharmacogenomics addresses these differences by examining genes
associated with drug metabolism, transportation, and receptor activity. Recent developments in genetic sequencing,
molecular diagnostics, and pharmacogenomic testing have created new opportunities for improving medication
selection, optimizing drug dosages, and reducing preventable adverse drug reactions. This research examines the
role of pharmacogenomics in personalized medicine development, with particular attention to its contribution to
individualized treatment, medication safety, and therapeutic effectiveness. It also investigates the applications of
genetic testing in modern clinical practice and evaluates the scientific, technological, ethical, and financial
challenges associated with its implementation. The study adopts a qualitative research methodology based on
secondary academic literature and previously published scientific investigations. The findings indicate that
pharmacogenomic information can support more informed prescribing decisions by identifying genetic variations
associated with different medication responses. Furthermore, integrating genetic information into clinical practice
may improve treatment planning and strengthen patient-centered healthcare. However, limited access to genetic
testing, high implementation costs, insufficient professional training, and concerns about genetic privacy remain
significant challenges. The research concludes that pharmacogenomics represents an important foundation for
advancing personalized medicine and developing safer, more effective, and individualized pharmacological
treatments.
Record
- Identifier
- https://doi-services.com/1141/233
- Published
- 2026-11-08
- Version
- 1